JP2010536752A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536752A5
JP2010536752A5 JP2010521009A JP2010521009A JP2010536752A5 JP 2010536752 A5 JP2010536752 A5 JP 2010536752A5 JP 2010521009 A JP2010521009 A JP 2010521009A JP 2010521009 A JP2010521009 A JP 2010521009A JP 2010536752 A5 JP2010536752 A5 JP 2010536752A5
Authority
JP
Japan
Prior art keywords
methyl
amino
carbamoyloxy
fluorophenyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010521009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536752A (ja
JP5670731B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/009636 external-priority patent/WO2009023193A1/en
Publication of JP2010536752A publication Critical patent/JP2010536752A/ja
Publication of JP2010536752A5 publication Critical patent/JP2010536752A5/ja
Application granted granted Critical
Publication of JP5670731B2 publication Critical patent/JP5670731B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010521009A 2007-08-15 2008-08-11 ある種の化学物質、組成物、および方法 Expired - Fee Related JP5670731B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96502007P 2007-08-15 2007-08-15
US60/965,020 2007-08-15
PCT/US2008/009636 WO2009023193A1 (en) 2007-08-15 2008-08-11 Certain chemical entities, compositions, and methods

Publications (3)

Publication Number Publication Date
JP2010536752A JP2010536752A (ja) 2010-12-02
JP2010536752A5 true JP2010536752A5 (OSRAM) 2014-01-09
JP5670731B2 JP5670731B2 (ja) 2015-02-18

Family

ID=40350992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010521009A Expired - Fee Related JP5670731B2 (ja) 2007-08-15 2008-08-11 ある種の化学物質、組成物、および方法

Country Status (14)

Country Link
US (3) US8088793B2 (OSRAM)
EP (1) EP2195328A4 (OSRAM)
JP (1) JP5670731B2 (OSRAM)
KR (1) KR20100044251A (OSRAM)
CN (1) CN101821279A (OSRAM)
AR (1) AR069364A1 (OSRAM)
AU (1) AU2008287435B2 (OSRAM)
CA (1) CA2696321A1 (OSRAM)
CL (1) CL2008002411A1 (OSRAM)
MX (1) MX2010001692A (OSRAM)
NZ (1) NZ583351A (OSRAM)
PE (1) PE20090958A1 (OSRAM)
TW (1) TWI426908B (OSRAM)
WO (1) WO2009023193A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071625B2 (en) * 2006-08-02 2011-12-06 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US8063082B2 (en) * 2006-08-02 2011-11-22 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
WO2009023193A1 (en) 2007-08-15 2009-02-19 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods
CA2817460A1 (en) 2010-12-17 2012-06-21 F. Hoffmann-La Roche Ag Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
WO2013138753A1 (en) 2012-03-16 2013-09-19 Fox Chase Chemical Diversity Center, Inc. Prodrugs of riluzole and their method of use
US20150065525A1 (en) * 2012-04-02 2015-03-05 Cytokinetics, Inc. Methods for improving diaphragm function
EP3176162B1 (en) 2012-07-19 2020-05-27 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
US9914725B2 (en) 2013-03-15 2018-03-13 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
AR108325A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
AR108326A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
CN110678466B (zh) 2017-03-30 2023-01-31 豪夫迈·罗氏有限公司 作为hpk1抑制剂的二氮杂萘类
MA48994A (fr) 2017-03-30 2020-02-05 Hoffmann La Roche Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
CN112533677A (zh) 2018-07-24 2021-03-19 豪夫迈·罗氏有限公司 萘啶化合物及其用途
JP7386841B2 (ja) 2018-07-24 2023-11-27 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト イソキノリン化合物及びその使用
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227709A (en) * 1961-11-28 1966-01-04 Merck & Co Inc Derivatives of cephalosporin c and process
GB1339764A (en) * 1971-03-29 1973-12-05 Ici Ltd Pyridine derivatives
DE2851953A1 (de) 1978-12-01 1980-06-19 Thomae Gmbh Dr K Neue spectinomycylamine, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel
JP2838148B2 (ja) 1991-08-15 1998-12-16 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
JPH07247274A (ja) 1994-03-10 1995-09-26 Wakamoto Pharmaceut Co Ltd ピバル酸 テトラゾリルフェニルエステル誘導体、それらを有効成分として含有するエラスターゼ阻害剤及び肺障害治療剤
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
WO1998041510A1 (en) * 1997-03-14 1998-09-24 Shionogi & Co., Ltd. Novel benzolactam derivatives and medicinal compositions comprising the same
EE200000294A (et) 1997-11-18 2001-08-15 Teijin Limited Tsüklilised amiini derivaadid ning meetod kemokiini seondumise sihtraku retseptoriga ja/või kemokiini toime sihtrakule inhibeerimiseks
US6107291A (en) * 1997-12-19 2000-08-22 Amgen Inc. Azepine or larger medium ring derivatives and methods of use
GB9807833D0 (en) * 1998-04-09 1998-06-10 Boc Group Plc Separation of air
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6410566B1 (en) 2000-05-16 2002-06-25 Teijin Limited Cyclic amine derivatives and their use as drugs
CA2321348A1 (en) 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
DE10063008A1 (de) * 2000-12-16 2002-06-20 Merck Patent Gmbh Carbonsäureamidderivate
AU2002342045C1 (en) * 2001-10-12 2009-07-30 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin Vla antagonists
TW200302728A (en) 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
BR0314071A (pt) * 2002-09-06 2005-07-05 Pharmacia & Upjohn Co Llc Derivados de pró-droga de 1,3-diamino-2-hidroxipropano
WO2004064730A2 (en) * 2003-01-14 2004-08-05 Cytokinetics, Inc. Compounds, compositions and methods
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
WO2004081005A1 (en) 2003-03-07 2004-09-23 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
GB0319124D0 (en) 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2005016883A2 (en) * 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
JP4380508B2 (ja) * 2003-11-28 2009-12-09 田辺三菱製薬株式会社 医薬組成物
WO2005074919A1 (en) * 2004-02-04 2005-08-18 Active Biotech Ab Diurea derivatives
CA2601709C (en) * 2005-03-22 2017-02-14 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids
JPWO2006137350A1 (ja) * 2005-06-22 2009-01-15 キッセイ薬品工業株式会社 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
US20070135435A1 (en) 2005-11-02 2007-06-14 Xiangping Qian Certain chemical entities, compositions, and methods
WO2007109615A2 (en) * 2006-03-21 2007-09-27 Azevan Pharmaceuticals, Inc. β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
MX2008012482A (es) 2006-03-31 2008-10-10 Abbott Lab Compuestos de indazol.
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
US20070293530A1 (en) 2006-06-14 2007-12-20 Methylgene Inc. Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
WO2008016676A2 (en) * 2006-08-02 2008-02-07 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods
US8063082B2 (en) 2006-08-02 2011-11-22 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US8071625B2 (en) 2006-08-02 2011-12-06 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
WO2009023193A1 (en) 2007-08-15 2009-02-19 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2010536752A5 (OSRAM)
US12157733B2 (en) Aminotriazolopyridines as kinase inhibitors
US11053234B2 (en) 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors
US11618753B2 (en) Aminopyrrolotriazines as kinase inhibitors
US11440913B2 (en) Aminoimidazopyridazines as kinase inhibitors
JP5552539B2 (ja) Cns障害の処置のためのオキサゾリン誘導体
JP6964576B2 (ja) 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
KR20140042848A (ko) Cb2 작용제로서 유용한 피리딘-2-아미드
JPWO2014084312A1 (ja) イミダゾピリジン化合物
KR20180110132A (ko) 무스카린성 아세틸콜린 수용체 m1의 양성 알로스테릭 조절제
US20160016907A1 (en) Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
WO2016153023A1 (ja) 新規オキサジアゾール誘導体及びこれを含有する医薬
RU2605600C2 (ru) Амино-замещенные производные 3-гетероароиламинопропионовой кислоты и их применение в качестве фармацевтических средств
JP7376358B2 (ja) オピオイド受容体調節因子としての多環式アミン
JP2012502035A (ja) ロイコトリエン産生のインドリジン阻害剤
US8394837B2 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
CA3153083A1 (en) Indazole carboxamides as kinase inhibitors
US20220009918A1 (en) Chemical Compounds
JP2023520005A (ja) Sstr4アゴニストとしてのn-ヘテロアリールアルキル-2-(ヘテロシクリル及びヘテロシクリルメチル)アセトアミド誘導体
JP2017521453A (ja) ピリジル−トリアザビシクル
JP2013540709A (ja) 糖尿病の処置における使用のためのbace阻害剤
JP2025500907A (ja) PLpro阻害剤
CN113015736B (zh) 用于诱导软骨发生以治疗关节损害的6-羟基-8-氧杂三环[3.2.1.02,4]辛烷-2-甲酰胺衍生物
WO2023279986A1 (zh) 六元芳基或杂芳基酰胺类化合物及其组合物和用途
WO2018079628A1 (ja) 縮環ピロール誘導体およびその医薬用途